REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN)

1,222 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2021.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 1,065 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 90,102,844 shares of 104,986,330 outstanding shares and own 85.82% of the company stock.
Largest 10 shareholders include FMR LLC (10,062,966 shares), BlackRock Inc. (9,610,870 shares), VANGUARD GROUP INC (8,158,515 shares), Capital World Investors (5,323,635 shares), STATE STREET CORP (4,799,822 shares), JPMORGAN CHASE & CO (4,591,529 shares), WELLINGTON MANAGEMENT GROUP LLP (3,134,775 shares), LOOMIS SAYLES & CO L P (2,629,151 shares), GEODE CAPITAL MANAGEMENT, LLC (1,977,302 shares), and PUTNAM INVESTMENTS LLC (1,343,603 shares).
This table shows the top 1065 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.